Welcome to our dedicated page for Infleqtion news (Ticker: INFQ), a resource for investors and traders seeking the latest updates and insights on Infleqtion stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Infleqtion's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Infleqtion's position in the market.
NYSE published a pre-market advisory for Feb 18, 2026, offering early market insights and IPO activity.
Intercontinental Exchange (NYSE: ICE) said its ICE Chat will integrate with crypto platform Kraken to expand institutional OTC communication. Infleqtion (NYSE: INFQ) closed up 14% at $15.59 on its Feb 17 NYSE debut. Duke Energy (NYSE: DUK) marks 100 consecutive years of paying a quarterly cash dividend.
Infleqtion (NYSE:INFQ) completed its business combination and began trading on the New York Stock Exchange, receiving more than $550 million of gross proceeds including nearly 100% of Churchill X trust cash and a $125M+ common stock PIPE.
Products include quantum computers, optical clocks, RF receivers and inertial sensors; customers and partners include NASA, U.S. Army, U.K. government, NVIDIA, and Voyager Technologies. Infleqtion will ring the NYSE opening bell on February 18, 2026.
Infleqtion (NYSE:INFQ) completed its business combination with Churchill Capital Corp X (CCCX) and will begin trading on the NYSE on February 17, 2026 under INFQ and INFQ WS. Churchill X has delisted from Nasdaq and its units have been separated and are no longer listed.
Infleqtion positions itself as the first publicly listed neutral-atom quantum technology company, offering quantum computers, precision sensors, clocks, RF receivers, inertial sensors, and proprietary software, with partnerships and customers including NVIDIA, the U.S. Department of War, NASA, and the U.K. government.
Infleqtion (NASDAQ: CCCX) announced that Founder & Chief Science Officer Dr. Dana Anderson was elected to the National Academy of Engineering for contributions to optical quantum engineering of ultracold atoms. The company also noted plans to go public via a merger with Churchill Capital Corp X.
Dr. Anderson will be honored at the NAE induction ceremony in October; the recognition underscores Infleqtion’s scientific credentials as it advances atom-based quantum sensing and computing.
Infleqtion (NASDAQ: CCCX) is a collaborator on NASA’s Quantum Gravity Gradiometer Pathfinder (QGGPf), a mission to fly the first standalone quantum gravity sensor in low Earth orbit. The program has more than $20 million in contracted mission funding to date and targets a one-year flight demonstration expected to launch in 2030.
Infleqtion will design and integrate the sensor's quantum core (vacuum, laser, control subsystems) and build on prior work with JPL and the Cold Atom Lab to advance space-based quantum sensing for Earth science, navigation, and security.
Infleqtion (NASDAQ: CCCX) executed a $6.2 million ARPA-E contract to launch the ENCODE program, developing quantum-enhanced methods for electricity grid optimization in partnership with Argonne, the National Laboratory of the Rockies, EPRI, and ComEd.
The company highlights a 1,600-qubit neutral-atom array and 12 logical qubits with error detection as technical foundations for scalable, energy-efficient grid solutions.
Infleqtion demonstrated a GPS-free quantum timing solution in partnership with Quantum Corridor, achieving up to 40X improvement over GPS and picosecond-level synchronization across 21.8 kilometers of live urban fiber between Chicago and Hammond, IN. The test used Infleqtion’s rack-mounted Tiqker atomic clock on Quantum Corridor’s purpose-built, quantum-safe fiber.
The collaboration supports commercial timing services for financial trading, data centers, telecom, and national security and follows Infleqtion’s planned merger to go public via Churchill Capital Corp X (NASDAQ: CCCX).
Infleqtion (NASDAQ: CCCX) was chosen to advance to Phase 3 of the Wellcome Leap Quantum for Bio (Q4Bio) Challenge to test quantum-enabled biomarker discovery on real oncology data. The team, with UChicago and MIT collaborators, will move experiments from simulation to real quantum processors and apply a hybrid quantum–classical workflow to forecast treatment response in head-and-neck cancer.
The announcement accompanies a new arXiv paper and comes as Infleqtion prepares to go public via a merger with Churchill Capital Corp X.